Tenax Therapeutics (TENX) Change in Interest Receivables (2020 - 2022)
Tenax Therapeutics (TENX) posted quarterly Change in Interest Receivables of -$1484.0 for Q2 2022, down 341.67% year-over-year from $614.07 in Q2 2021, and up 42.64% on a QoQ basis from -$2587.0 in Q1 2022.
Tenax Therapeutics (TENX) Change in Interest Receivables (2020 - 2022) Analysis & Trends
Tenax Therapeutics has reported Change in Interest Receivables for 3 years, with the latest figure at -$1484.0 in Q2 2022.
- Change in Interest Receivables for Q2 2022 came in at -$1484.0, down 341.67% year-over-year; the trailing twelve-month figure through Jun 2022 was -$4071.0 (down 36.52% YoY), and the FY2021 annual result was -$949.0, up 41.67% from the prior year.
- Change in Interest Receivables grew to -$1484.0 in Q2 2022, from -$2587.0 in the prior quarter.
- Over five years, Change in Interest Receivables peaked at $1898.0 in Q3 2021 and troughed at -$2643.0 in Q4 2020.
- A 3-year average of -$738.56 and a median of -$613.0 in 2021 frame the typical range for Change in Interest Receivables.
- The widest annual swing landed in 2021, when Change in Interest Receivables surged 211.15%; it then plunged 341.67% in 2022.
- A 3-year view of Change in Interest Receivables shows it stood at -$2643.0 in 2020, then climbed by 28.19% to -$1898.0 in 2021, then gained by 21.81% to -$1484.0 in 2022.
- Per Business Quant data, the three most recent Change in Interest Receivables figures were -$1484.0 in Q2 2022, -$2587.0 in Q1 2022, and -$1898.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,484.00 |
| Mar 31, 2022 | -2,587.00 |
| Dec 31, 2021 | -1,898.00 |
| Sep 30, 2021 | 1,898.00 |
| Jun 30, 2021 | -336.00 |
| Mar 31, 2021 | -613.00 |
| Dec 31, 2020 | -2,643.00 |
| Sep 30, 2020 | 610.00 |
| Jun 30, 2020 | 406.00 |